Cargando…

Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders

Background: The G protein–coupled receptor (GPCR) trace amine-associated receptor 1 (TAAR1) is expressed across brain areas involved in emotions, reward and cognition, and modulates monoaminergic and glutamatergic neurotransmissions. TAAR1 is stimulated with nanomolar affinity by 3-iodothyronamine (...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutigliano, Grazia, Bräunig, Julia, Del Grande, Claudia, Carnicelli, Vittoria, Masci, Isabella, Merlino, Sergio, Kleinau, Gunnar, Tessieri, Luca, Pardossi, Simone, Paisdzior, Sarah, Dell’Osso, Liliana, Biebermann, Heike, Zucchi, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753877/
https://www.ncbi.nlm.nih.gov/pubmed/31572197
http://dx.doi.org/10.3389/fphar.2019.01027
_version_ 1783452980750581760
author Rutigliano, Grazia
Bräunig, Julia
Del Grande, Claudia
Carnicelli, Vittoria
Masci, Isabella
Merlino, Sergio
Kleinau, Gunnar
Tessieri, Luca
Pardossi, Simone
Paisdzior, Sarah
Dell’Osso, Liliana
Biebermann, Heike
Zucchi, Riccardo
author_facet Rutigliano, Grazia
Bräunig, Julia
Del Grande, Claudia
Carnicelli, Vittoria
Masci, Isabella
Merlino, Sergio
Kleinau, Gunnar
Tessieri, Luca
Pardossi, Simone
Paisdzior, Sarah
Dell’Osso, Liliana
Biebermann, Heike
Zucchi, Riccardo
author_sort Rutigliano, Grazia
collection PubMed
description Background: The G protein–coupled receptor (GPCR) trace amine-associated receptor 1 (TAAR1) is expressed across brain areas involved in emotions, reward and cognition, and modulates monoaminergic and glutamatergic neurotransmissions. TAAR1 is stimulated with nanomolar affinity by 3-iodothyronamine (T1AM), an endogenous messenger considered a novel branch of thyroid hormone signaling. The human gene for TAAR1 maps to locus 6q23, within a region associated with major mental disorders. Materials and Methods: We screened a cohort of patients with major mental disorders (n = 104) and a group of healthy controls (n = 130) for TAAR1 variants. HEK293 cells were transiently transfected with: i) wild-type TAAR1 and ii) mutated TAAR1, either in homozygous or heterozygous state. Cell surface expression and Gs/adenylyl cyclase activation upon administration of β-phenylethylamine (PEA), T1AM, and RO5166017, were assessed. Results: We detected 13 missense variants in TAAR1 coding region, with a significant enrichment in patients as compared to healthy controls (11 vs. 1, 1 variant in both groups, p < 0.01). In silico analysis identified four dysfunctional variants, all in patients. Three of these—R23C, Y131C, and C263R—were functionally characterized. In cells co-transfected with wild-type and mutated TAAR1, we observed a significant reduction of cell surface expression. In heterozygosity, the three TAAR1 variants substantially dampened Gs signaling in response to PEA, and, more robustly, to T1AM. Co-stimulation with PEA and RO5166017 did not yield any improvement in Gs signaling. R23C, Y131C, and C263R are rare in the general population and map in functionally important highly conserved positions across TAAR1 orthologous and paralogous genes. Conclusions: Our findings suggest that disruptions of TAAR1 activity may be relevant to the pathophysiology of mental disorders, thereby providing a promising target for novel psychopharmacological interventions.
format Online
Article
Text
id pubmed-6753877
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67538772019-09-30 Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders Rutigliano, Grazia Bräunig, Julia Del Grande, Claudia Carnicelli, Vittoria Masci, Isabella Merlino, Sergio Kleinau, Gunnar Tessieri, Luca Pardossi, Simone Paisdzior, Sarah Dell’Osso, Liliana Biebermann, Heike Zucchi, Riccardo Front Pharmacol Pharmacology Background: The G protein–coupled receptor (GPCR) trace amine-associated receptor 1 (TAAR1) is expressed across brain areas involved in emotions, reward and cognition, and modulates monoaminergic and glutamatergic neurotransmissions. TAAR1 is stimulated with nanomolar affinity by 3-iodothyronamine (T1AM), an endogenous messenger considered a novel branch of thyroid hormone signaling. The human gene for TAAR1 maps to locus 6q23, within a region associated with major mental disorders. Materials and Methods: We screened a cohort of patients with major mental disorders (n = 104) and a group of healthy controls (n = 130) for TAAR1 variants. HEK293 cells were transiently transfected with: i) wild-type TAAR1 and ii) mutated TAAR1, either in homozygous or heterozygous state. Cell surface expression and Gs/adenylyl cyclase activation upon administration of β-phenylethylamine (PEA), T1AM, and RO5166017, were assessed. Results: We detected 13 missense variants in TAAR1 coding region, with a significant enrichment in patients as compared to healthy controls (11 vs. 1, 1 variant in both groups, p < 0.01). In silico analysis identified four dysfunctional variants, all in patients. Three of these—R23C, Y131C, and C263R—were functionally characterized. In cells co-transfected with wild-type and mutated TAAR1, we observed a significant reduction of cell surface expression. In heterozygosity, the three TAAR1 variants substantially dampened Gs signaling in response to PEA, and, more robustly, to T1AM. Co-stimulation with PEA and RO5166017 did not yield any improvement in Gs signaling. R23C, Y131C, and C263R are rare in the general population and map in functionally important highly conserved positions across TAAR1 orthologous and paralogous genes. Conclusions: Our findings suggest that disruptions of TAAR1 activity may be relevant to the pathophysiology of mental disorders, thereby providing a promising target for novel psychopharmacological interventions. Frontiers Media S.A. 2019-09-13 /pmc/articles/PMC6753877/ /pubmed/31572197 http://dx.doi.org/10.3389/fphar.2019.01027 Text en Copyright © 2019 Rutigliano, Bräunig, Del Grande, Carnicelli, Masci, Merlino, Kleinau, Tessieri, Pardossi, Paisdzior, Dell’Osso, Biebermann and Zucchi http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Rutigliano, Grazia
Bräunig, Julia
Del Grande, Claudia
Carnicelli, Vittoria
Masci, Isabella
Merlino, Sergio
Kleinau, Gunnar
Tessieri, Luca
Pardossi, Simone
Paisdzior, Sarah
Dell’Osso, Liliana
Biebermann, Heike
Zucchi, Riccardo
Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
title Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
title_full Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
title_fullStr Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
title_full_unstemmed Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
title_short Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
title_sort non-functional trace amine-associated receptor 1 variants in patients with mental disorders
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753877/
https://www.ncbi.nlm.nih.gov/pubmed/31572197
http://dx.doi.org/10.3389/fphar.2019.01027
work_keys_str_mv AT rutiglianograzia nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT braunigjulia nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT delgrandeclaudia nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT carnicellivittoria nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT masciisabella nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT merlinosergio nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT kleinaugunnar nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT tessieriluca nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT pardossisimone nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT paisdziorsarah nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT dellossoliliana nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT biebermannheike nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders
AT zucchiriccardo nonfunctionaltraceamineassociatedreceptor1variantsinpatientswithmentaldisorders